TrianglePUBLICATIONS · 38194625
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Mar 1
- First author
- Kahl BS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kahl BS
- type
- Author
- name
- Jegede OA
- type
- Author
- name
- Peterson C
- type
- Author
- name
- Swinnen LJ
- type
- Author
- name
- Habermann TM
- type
- Author
- name
- Schuster SJ
- type
- Author
- name
- Weiss M
- type
- Author
- name
- Fishkin PA
- type
- Author
- name
- Fenske TS
- type
- Author
- name
- Williams ME
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kahl BS
- type
- Author
- name
- Jegede OA
- type
- Author
- name
- Peterson C
- type
- Author
- name
- Swinnen LJ
- type
- Author
- name
- Habermann TM
- type
- Author
- name
- Schuster SJ
- type
- Author
- name
- Weiss M
- type
- Author
- name
- Fishkin PA
- type
- Author
- name
- Fenske TS
- type
- Author
- name
- Williams ME
- type
- Author
- bibliography ids
- nci-bib-1a5bed9873b81c16b05b21fb
- book metadata
- content sha256
- 5231a38aef9cda54803f29df52481573e9aaecc7e823950400da45033de4ef47
- document type
- citation
- dois
- 10.1200/JCO.23.01912
- electronic publication date
- display
- 2024 Jan 9
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38194625
- immutable id
- pubmed:38194625@5231a38aef9cda54803f29df52481573e9aaecc7e823950400da45033de4ef47
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 7
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 774-778
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38194625
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 73b0720a52eff908345bb12be820759cf86d82c7cec291d1ffddc48ddfd5a784
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Mar 1
- precision
- day
- year
- 2024
- publication types
- Randomized Controlled Trial
- Clinical Trial, Phase III
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
Preserved source evidence · Independent clinical review pending · Not medical advice